- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4164 - 1,3-Diazoles
Patent holdings for IPC class A61K 31/4164
Total number of patents in this class: 2537
10-year publication summary
|
163
|
152
|
194
|
187
|
181
|
188
|
184
|
120
|
148
|
135
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20153 |
28 |
| Allergan, Inc. | 2329 |
27 |
| Evofem Biosciences, Inc. | 47 |
19 |
| Centre National de La Recherche Scientifique | 10595 |
17 |
| Bristol-myers Squibb Company | 4840 |
15 |
| F. Hoffmann-La Roche AG | 7946 |
15 |
| The Cleveland Clinic Foundation | 1569 |
15 |
| Novartis AG | 10707 |
14 |
| FUJIFILM Corporation | 29713 |
14 |
| Cedars-Sinai Medical Center | 1167 |
14 |
| Journey Medical Corporation | 94 |
14 |
| University of Tennessee Research Foundation | 753 |
14 |
| The Regents of the University of Michigan | 4752 |
12 |
| Astellas Pharma Inc. | 1071 |
12 |
| Enanta Pharmaceuticals, Inc. | 432 |
12 |
| Pharnext | 90 |
12 |
| Abbvie Inc. | 1800 |
11 |
| Antecip Bioventures II LLC | 340 |
10 |
| Celltrion, Inc. | 350 |
10 |
| Galderma Research & Development | 397 |
10 |
| Other owners | 2242 |